These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23978031)

  • 21. Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran.
    Alimoghaddam K; Ghavamzadeh A; Jahani M; Jalali A; Jorjani H; Iravani M; Hamidieh AA; Mousavi A; Bahar B; Behfar M; Derakhshandeh R; Rostami S
    Arch Iran Med; 2011 Sep; 14(5):332-4. PubMed ID: 21888457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation.
    Elmaagacli AH; Beelen DW; Trenschel R; Schaefer UW
    Bone Marrow Transplant; 2000 Jan; 25(1):91-6. PubMed ID: 10654021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.
    Baron F; Frère P; Fillet G; Beguin Y
    Haematologica; 2001 Sep; 86(9):993-4. PubMed ID: 11532632
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
    Chin Med J (Engl); 2012 Jun; 125(11):1952-9. PubMed ID: 22884060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation.
    Kurosawa S; Fukuda T; Tajima K; Saito B; Fuji S; Yokoyama H; Kim SW; Mori S; Tanosaki R; Heike Y; Takaue Y
    Am J Hematol; 2009 Dec; 84(12):815-20. PubMed ID: 19899134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
    Wang Y; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Shi HX; Zhang YC; Wang JZ; Zhang XU; Chen Y; Huang XJ; Lu DP
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):903-6. PubMed ID: 18261271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis.
    Wang Y; Liu DH; Xu LP; Liu KY; Chen H; Zhang XH; Chen YH; Han W; Wang FR; Wang JZ; Yan CH; Huang XJ
    Bone Marrow Transplant; 2012 Aug; 47(8):1099-104. PubMed ID: 22056641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity.
    Zhao XS; Yan CH; Liu DH; Xu LP; Liu YR; Liu KY; Qin YZ; Wang Y; Huang XJ
    Ann Hematol; 2013 Aug; 92(8):1111-9. PubMed ID: 23680867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
    Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
    Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation.
    Kumar AJ; Hexner EO; Frey NV; Luger SM; Loren AW; Reshef R; Boyer J; Smith J; Stadtmauer EA; Levine BL; June CH; Porter DL; Goldstein SC
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1094-101. PubMed ID: 23635453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extramedullary relapse of acute lymphoblastic leukemia in the breast after allogeneic stem cell transplantation and concomitant persistence of donor hematopoiesis.
    Manna A; Magli T
    Haematologica; 2001 Jul; 86(7):767-8. PubMed ID: 11454536
    [No Abstract]   [Full Text] [Related]  

  • 35. A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation.
    Clave E; Lisini D; Douay C; Giorgiani G; Busson M; Zecca M; Charron D; Bernardo ME; Toubert A; Locatelli F
    Leukemia; 2012 Aug; 26(8):1886-8. PubMed ID: 22430571
    [No Abstract]   [Full Text] [Related]  

  • 36. Leukemia relapse after allogeneic bone marrow transplantation: how does chronic graft-versus-host disease influence the pattern and onset of relapse?
    Al Beihany A; Al Mohareb F; Al Zahrani H; Alsharif F; Chaudhri N; Mohamed SY; Rasheed W; Aljurf M
    Exp Clin Transplant; 2011 Dec; 9(6):432-3. PubMed ID: 22142055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
    Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
    Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effects of donor peripheral blood stem cell infusion in the prevention of relapse in high risk leukemia after haplotype hematopoietic stem cell transplantation].
    Zhang Y; Chen HR; Liu XD; He XP; Lou JX; Guo Z
    Zhonghua Nei Ke Za Zhi; 2011 Jun; 50(6):492-5. PubMed ID: 21781534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The efficacy and safety of second allogeneic hematopoietic stem cell transplantation for post-transplant hematologic malignancies relapse].
    Chen YH; Xu LP; Chen H; Liu DH; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Zhang YY; Yan CH; Sun YQ; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2011 Jun; 50(6):489-91. PubMed ID: 21781533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
    Zohren F; Czibere A; Bruns I; Fenk R; Schroeder T; Gräf T; Haas R; Kobbe G
    Bone Marrow Transplant; 2009 Dec; 44(12):785-92. PubMed ID: 19430496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.